Hepatitis C Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Alerts
• Clinical Trials
• Forums

Elimination of Hepatitis C Virus Among Users of Substances
Condition:   Hepatitis C in Substance Users Intervention:   Drug: Sofosbuvir 400 MG / Velpatasvir 100 MG [Epclusa] Sponsors:   Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran;   Gilead Sciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 17, 2022 Category: Research Source Type: clinical trials